Bibliometric analysis of the top-cited publications and research trends for stereotactic body radiotherapy

Y Liu, J Li, X Cheng, X Zhang - Frontiers in Oncology, 2021 - frontiersin.org
Objective This study aims to analyze the 100 most cited papers and research trends on
stereotactic body radiotherapy (SBRT). Methods We used Web of Science to identify the 100 …

Lung stereotactic body radiation therapy for elderly patients aged≥ 80 years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort …

K Watanabe, K Katsui, S Sugiyama, K Yoshio… - Radiation …, 2021 - Springer
Background Stereotactic body radiation therapy (SBRT) is an established therapy for
medically inoperable early-stage non-small cell lung cancer (NSCLC). Many elderly patients …

Percutaneous lung thermal ablation of non-surgical clinical N0 non-small cell lung cancer: results of eight years' experience in 87 patients from two centers

J Palussiere, P Lagarde, A Aupérin… - Cardiovascular and …, 2015 - Springer
Purpose To evaluate the survival outcomes of percutaneous thermal ablation (RFA+
microwaves) for patients presenting N0 non-small-cell lung cancer (NSCLC) ineligible for …

Prospective Cohort Study to Compare Long-Term Lung Cancer-Specific and All-Cause Survival of Clinical Early Stage (T1a–b;≤ 20 mm) NSCLC Treated by …

CI Henschke, R Yip, Q Sun, P Li, A Kaufman… - Journal of Thoracic …, 2024 - Elsevier
Introduction We aimed to compare outcomes of patients with first primary clinical T1a-
bN0M0 NSCLC treated with surgery or stereotactic body radiation therapy (SBRT). Methods …

Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer

D Palma, S Senan - Current opinion in oncology, 2011 - journals.lww.com
In patients with stage I NSCLC who do not undergo surgery, SBRT achieves superior
survival as compared to treatment using conventionally fractionated radiotherapy. The role …

Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors

N Trakul, CN Chang, J Harris, C Chapman… - International Journal of …, 2012 - Elsevier
PURPOSE: Current stereotactic ablative radiotherapy (SABR) protocols for lung tumors
prescribe a uniform dose regimen irrespective of tumor size. We report the outcomes of a …

A promising treatment strategy for lung cancer: a combination of radiotherapy and immunotherapy

Y Miyasaka, H Sato, N Okano, N Kubo, H Kawamura… - Cancers, 2021 - mdpi.com
Simple Summary Lung cancer is a leading cause of cancer-related deaths worldwide. In the
past few decades, radiotherapy has achieved outstanding technical advances and is widely …

Local recurrence after microwave ablation of lung malignancies: a systematic review

DB Nelson, AL Tam, KG Mitchell, DC Rice… - The Annals of Thoracic …, 2019 - Elsevier
Background Microwave ablation is a therapeutic option for patients with lung malignancies
who are not surgical candidates. However, reports on local recurrence have been limited to …

Clinical staging of stage I non-small cell lung cancer in the Netherlands—need for improvement in an era with expanding nonsurgical treatment options: data from the …

DJ Heineman, MG Ten Berge, JM Daniels… - The Annals of Thoracic …, 2016 - Elsevier
Background The clinical stage of non-small cell lung cancer (NSCLC) determines the initial
treatment, whereas the pathologic stage best determines prognosis and the need for …

Stereotactic body radiotherapy for early-stage multiple primary lung cancers

J Nikitas, T DeWees, S Rehman, C Abraham… - Clinical lung cancer, 2019 - Elsevier
Background Patients with multiple primary lung cancers increasingly receive multiple
courses of stereotactic body radiotherapy (SBRT). We aimed to clarify the efficacy and safety …